about
Molecular biology of lung cancerp90 ribosomal S6 kinase: a potential therapeutic target in lung cancerPromotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line modelExposure of Human Lung Cells to Tobacco Smoke Condensate Inhibits the Nucleotide Excision Repair PathwayLung cancer in womenMusical patterns for comparative epigenomics.Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells.The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club.Serum folate concentration and the incidence of lung cancer.MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.Argyrophilic nucleolar organizer region in MIB-1 positive cells in non-small cell lung cancer: clinicopathological significance and survivalOncogenic mutation profiling in new lung cancer and mesothelioma cell lines.Isorhamnetin flavonoid synergistically enhances the anticancer activity and apoptosis induction by cis-platin and carboplatin in non-small cell lung carcinoma (NSCLC).Potential crosstalk between cofilin-1 and EGFR pathways in cisplatin resistance of non-small-cell lung cancerAn ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K SignalingGenomic classification of the RAS network identifies a personalized treatment strategy for lung cancerOncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.Cellular and molecular immunology of lung cancer: therapeutic implications.Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.TPL2 kinase is a suppressor of lung carcinogenesisThe pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas.Establishment and application of a multiplex genetic mutation-detection method of lung cancer based on MassARRAY platform.Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations.miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor.The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activitiesZEB1 drives epithelial-to-mesenchymal transition in lung cancer.Genome-wide identification of genes with amplification and/or fusion in small cell lung cancerEpiregulin as a therapeutic target in non-small-cell lung cancerFGFR3 silencing by siRNA inhibits invasion of A549 cellsVGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.Radiation-enhanced lung cancer progression in a transgenic mouse model of lung cancer is predictive of outcomes in human lung and breast cancerElevated expression of STIM1 is involved in lung tumorigenesis.Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinomaFrequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.Monoclonal antibodies in lung cancer.Surgery for NSCLC in the era of personalized medicine.Regulatory single nucleotide polymorphisms at the beginning of intron 2 of the human KRAS gene.Bone metastases in lung cancer. Potential novel approaches to therapy.Inhibition of p90 ribosomal S6 kinase attenuates cell migration and proliferation of the human lung adenocarcinoma through phospho-GSK-3β and osteopontin.
P2860
Q24606677-F068DDAC-DDF5-4321-83BD-C4BB19864184Q28077322-047E63E0-106F-4150-833C-FDA12BFEB523Q28384920-1FE7CD3B-4AA7-4673-BEA5-2066A2ECC3E9Q28552525-AA16E01E-D7E7-4AFB-992A-E65C50BBF6E2Q29248783-98019D9A-02A3-48A6-8DA8-9CB62FEBFD23Q30379034-923F8525-2E87-4227-A10A-3F347BC65777Q33631023-67CF3D2C-A24E-4175-86BF-354AB116E703Q33658238-F83CD137-C509-4815-AEB7-9D9193D2080BQ33664315-8286720F-E415-423C-99F7-EC5FA79FD345Q33913045-841BA02E-C4AC-4178-8A4B-627082305B57Q34404209-941E4882-3E71-46FA-AD93-0077DFE8A103Q34974392-ED750C7D-0127-422D-AB45-E2A3CFC4B99AQ35001781-AE0CBBBC-55E9-4A7A-8504-85B07E9D24D8Q35144843-44348BC2-CDC3-4A0F-B82C-DCCABDE028E1Q35551805-1F6BE3B0-9638-4DBE-AE48-2F1AF0842CF5Q35593321-26EE8385-2B54-49D1-8659-EA25A04466EFQ35670290-F1C0EA2F-BFCE-4873-882E-4FBF0A6A994BQ35671281-2E7B986E-8A3B-4D70-AD25-0F476D226D33Q36130505-2D78E2E1-71A0-496F-A2A2-C2F4BAAC3359Q36660664-22F617F7-016A-476D-87BD-A4D6DFC2BF1BQ36781882-E5331C7F-B5A9-4ED6-A763-5A3BECCD0070Q36829459-866996E5-63B5-4204-B742-962FDAA6DA40Q36849673-78A3E684-0D9E-4A4F-AB64-CFE501FE4046Q36941497-DC181E9D-739C-48CF-961C-9F24308E26B4Q36983803-80A7728F-3F06-4E71-B6F4-FA319CF8AC90Q37132018-51093858-BE69-4564-A27B-E8563935D8E5Q37217422-3998C505-6BB1-4B09-99CA-00ADB033C672Q37250224-70DDC949-057A-4CF0-868C-DBB8298B9BC9Q37566850-13241C57-9F25-41C3-8E98-31D096C08100Q37582147-360DB7BD-7C09-4AB8-9B7E-15E627B45AF4Q37623587-DD582810-8CA1-4166-9AA7-A7DC2EA345E5Q37653607-889A08D0-9EC3-420E-B413-35CF629928D5Q37699292-E8272C3E-8848-4C93-BFBC-A959AEC3913EQ37709086-4EDCD786-7209-4499-9FE8-773CE5B88DA6Q37709397-6160FF7D-B346-4368-AF16-0AB430A7FE32Q38067454-CAD5FFFF-D413-49CB-9852-4E53B2EB5E0AQ38084427-6D5EFC57-1FE2-454F-A5ED-963977BFBF23Q38294882-95F598D4-A76D-4493-A3E9-1C7E622B369EQ38541387-AAE42A1B-8D65-4FBB-804F-9DAB6463B042Q38767694-EBA7661E-0BB6-4776-9D65-C15A004DC8D5
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular biology of lung cancer: clinical implications
@ast
Molecular biology of lung cancer: clinical implications
@en
Molecular biology of lung cancer: clinical implications
@nl
type
label
Molecular biology of lung cancer: clinical implications
@ast
Molecular biology of lung cancer: clinical implications
@en
Molecular biology of lung cancer: clinical implications
@nl
prefLabel
Molecular biology of lung cancer: clinical implications
@ast
Molecular biology of lung cancer: clinical implications
@en
Molecular biology of lung cancer: clinical implications
@nl
P2860
P3181
P1476
Molecular biology of lung cancer: clinical implications
@en
P2093
John D Minna
P2860
P304
P3181
P356
10.1016/J.CCM.2011.08.003
P407
P577
2011-12-01T00:00:00Z